Check Cap Stock

Check Cap EBIT Growth

The Year-over-Year EBIT Growth of Check Cap (MBAI) as of Aug 9, 2026 is 90.86 %. In the previous year, Year-over-Year EBIT Growth was -34.54 % — a change of -363.03% (higher).

EBIT Growth

90.86 %

YoY

-363.03%

Last updated:

Year-over-Year EBIT Growth of Check Cap is 2026 90.86 % . Year-over-Year EBIT Growth of Check Cap was 2025 -34.54 % . It decreases by -363.03% higher compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

Year-over-Year EBIT Growth of Check Cap is 90.86 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Check Cap since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Check Cap historically and in real time.

Access this data via the Eulerpool API

Growth — Check Cap

All Key Metrics — Check Cap